Copay assistance fund status, eligibility, and covered drugs — for patient access and billing teams.
Maximum award Contact PAN · Income ≤500% FPL · Covers drug cost only — administration billed separately
Published terms from the foundation. Per-patient eligibility and amounts are confirmed at application.
K50.0 K50.00 K50.1 K50.10 K50.8 K50.80 K50.9 K50.90 K51.0 K51.00 K51.2 K51.20 K51.3 K51.30 K51.5 K51.50 K51.8 K51.80 K51.9 K51.90Drugs whose J-codes this fund matches. Each links to its billing & coding reference.
Also matches J-codes not yet in our drug library: J0139
Fund status changes with donations, often without an announcement — confirm directly with the foundation at 866-316-7263, and check the alternatives below.
Manufacturer copay programs may also apply — see the drug pages: Cimzia, Remicade / biosimilars, Omvoh, Tysabri.
Status shown as of each fund's last verification.
As of June 3, 2026, the PAN Foundation Ulcerative Colitis fund is CLOSED to new applications. Fund status changes with donations — call the foundation to confirm before turning a patient away. Verify at time of service: 866-316-7263.
Contact PAN. Covers drug cost only — administration billed separately
Household income must be ≤500% FPL. US resident.
Accepted: commercial, medicare. Not eligible: medicaid.
The foundation's published processing time is 5–10 business days. Renewal: annual reapplication.